Business
Vietnam Approves Biomerica’s EZ Detect™ for Nationwide Distribution
Approval Marks Biomerica’s Strategic Entry into Southeast Asia’s Rapidly Growing Healthcare MarketSimple, FDA-Cleared At-Home Test Detects an Early Warning
About this update from Biomerica, Inc.
[{"type":"text","content":"Approval Marks Biomerica’s Strategic Entry into Southeast Asia’s Rapidly Growing Healthcare MarketSimple, FDA-Cleared At-Home Test Detects an Early Warning Sign of Colorectal Cancer in Minutes IRVINE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced diagnostic solutions, announced that Vietnam’s Hanoi Department of Health has officially approved the EZ Detect™ colorectal disease at-home screening test for sales and distribution throughout Vietnam. Biomerica is working with a major healthcare products distributor in Vietnam who will manage the sales and distribution of the product through pharmacies, hospitals, physician’s offices, and direct online sales channels. EZ Detect™ is an FDA-cleared two-minute at-home screening test designed to detect an early warning sign of colorectal cancer and other colorectal diseases. This regulatory approval represents a milestone in Biomerica’s strategic global expansion into Southeast Asia, a region with over 680 million people and rapidly growing healthcare spending. Addressing a Critical Public Health Need in Vietnam Colorectal cancer (“CRC”) is a growing public health crisis in Vietnam, a nation of over 100 million people. According to the most recent 2022 data, Vietnam recorded 16,835 new cases of colorectal cancer, making it the fourth most common cancer in the country, accounting for 9.3% of all cancer cases. Critically, the five-year survival rate for Vietnamese patients with colorectal cancer has been reported at only 45%, significantly below the 91% survival rate achieved in the United States when colorectal cancer is detected early at a localized stage. This disparity underscores the urgent and largely unmet need for accessible, affordable early-detection solutions in Vietnam. Key Benefits of EZ Detect™ Early Detection: EZ Detect™ identifies occult (hidden) blood in the stool which can be an early indicator of colorectal diseases, including cancer. Early detection is the single most important factor in improving colorectal cancer survival outcomes.User-Friendly and No Stool Handling: The test requires no special preparation or dietary restrictions. Unlike competing tests, EZ Detect™ does not require a person to touch or handle stool and can be completed in the privacy of one’s home without the unpleasantness of handling and maili...